Page last updated: 2024-11-04

tegafur and Inappropriate ADH Syndrome

tegafur has been researched along with Inappropriate ADH Syndrome in 2 studies

Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.

Research Excerpts

ExcerptRelevanceReference
"A 78-year-old man with advanced gastric cancer was treated with S-1 and oxaliplatin chemotherapy."2.52[Onset of Syndrome of Inappropriate Secretion of Antidiuretic Hormone in a Gastric Cancer Patient on SOX Treatment]. ( Goto, Y; Inagaki, S; Kaneko, S; Kobayashi, T; Wakita, S; Yoshimitsu, M, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, Y1
Wakita, S1
Yoshimitsu, M1
Inagaki, S1
Kobayashi, T1
Kaneko, S1
Kusuki, M1
Iguchi, H1
Nakamura, A1
Nishiura, H1
Kanazawa, A1
Yamane, H1

Reviews

1 review available for tegafur and Inappropriate ADH Syndrome

ArticleYear
[Onset of Syndrome of Inappropriate Secretion of Antidiuretic Hormone in a Gastric Cancer Patient on SOX Treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:13

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug

2015

Other Studies

1 other study available for tegafur and Inappropriate ADH Syndrome

ArticleYear
The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
    Acta oto-laryngologica. Supplementum, 2004, Issue:554

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; D

2004